Head-to-head effectiveness and safety of pembrolizumab plus axitinib vs. nivolumab plus ipilimumab in metastatic renal cell carcinoma in the United States.

被引：0
|
作者：
Aran, Dvir
Granot-Hershkovitz, Einat
Amar-Farkash, Shlomit
Rosenberg-Katz, Keren
机构：
[1] Technion Israel Inst Technol, Fac Biol, Haifa, Israel
[2] Carelon Digital Platforms, Tel Aviv, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4532
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of nivolumab plus ipilimumab in patients with metastatic variant histology (non-clear cell) renal cell carcinoma
    Moussa, Mohammad Jad
    Khandelwal, Jaanki
    Wilson, Nathaniel R.
    Malikayil, Kiran L.
    Surasi, Devaki Shilpa
    Bathala, Tharakeswara K.
    Lin, Yiyun
    Rao, Priya
    Tamboli, Pheroze
    Sircar, Kanishka
    Ajufo, Helen
    Elsayes, Khaled M.
    Shah, Amishi
    Johns, Andrew C.
    Goswami, Sangeeta
    Hasanov, Elshad
    Jonasch, Eric
    Msaouel, Pavlos
    Campbell, Matthew T.
    Alhalabi, Omar
    Tannir, Nizar M.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (02)
  • [42] Efficacy of Pembrolizumab vs. Nivolumab Plus Ipilimumab in Metastatic NSCLC in Relation to PD-L1 and TMB Status
    Shalata, Walid
    Maimon Rabinovich, Natalie
    Agbarya, Abed
    Yakobson, Alexander
    Dudnik, Yulia
    Abu Jama, Ashraf
    Cohen, Ahron Yehonatan
    Shalata, Sondos
    Abu Hamed, Ahmad
    Ilan Ber, Tahel
    Machluf, Oshri
    Shoham Levin, Gal
    Meirovitz, Amichay
    CANCERS, 2024, 16 (10)
  • [43] Combination Therapy of Pembrolizumab plus Axitinib for a Patient on Hemodialysis with Metastatic Renal Cell Carcinoma: A Case Report
    Katsumata, Yuki
    Kawasaki, Yoshihide
    Tanaka, Kayu
    Nakayama, Daisuke
    Katayama, Hiromichi
    Shimada, Shuichi
    Satake, Yohei
    Sato, Takuma
    Kawamorita, Naoki
    Yamashita, Shinichi
    Sato, Testuya
    Shoji, Kosuke
    Mitsuzuka, Koji
    Ito, Akihiro
    CASE REPORTS IN ONCOLOGY, 2021, 14 (03): : 1522 - 1529
  • [44] Effectiveness and Safety of Molecular-Targeted Therapy after Nivolumab Plus Ipilimumab for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study
    Iinuma, Koji
    Kameyama, Koji
    Taniguchi, Tomoki
    Kawada, Kei
    Ishida, Takashi
    Takagi, Kimiaki
    Nagai, Shingo
    Enomoto, Torai
    Tomioka, Masayuki
    Kawase, Makoto
    Takeuchi, Shinichi
    Kato, Daiki
    Takai, Manabu
    Nakane, Keita
    Koie, Takuya
    CANCERS, 2022, 14 (19)
  • [45] COST-EFFECTIVENESS OF NIVOLUMAB plus IPILIMUMAB IN FIRST-LINE TREATMENT OF ADVANCED OR METASTATIC RENAL CELL CARCINOMA IN THE NETHERLANDS
    Klijn, S.
    Van de Wetering, G.
    Malcolm, B.
    Dale, P.
    Pompen, M.
    Stevanovic, J.
    VALUE IN HEALTH, 2018, 21 : S46 - S46
  • [46] Efficacy and Safety of Nivolumab Plus Ipilimumab for Metastatic Renal Cell Carcinoma in Patients 75 Years and Older: Multicenter Retrospective Study
    Yamashita, Shimpei
    Hamamoto, Shuzo
    Furukawa, Junya
    Fujita, Kazutoshi
    Takahashi, Masayuki
    Miyake, Makito
    Ito, Noriyuki
    Iwamoto, Hideto
    Kohjimoto, Yasuo
    Hara, Isao
    CANCERS, 2025, 17 (03)
  • [47] Efficacy and safety of first-line nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma: A multicenter retrospective study
    Tanaka, Toshikazu
    Hatakeyama, Shingo
    Numakura, Kazuyuki
    Kido, Koichi
    Noro, Daisuke
    Oikawa, Masaaki
    Hosogoe, Shogo
    Tokui, Noriko
    Yamamoto, Hayato
    Narita, Shintaro
    Ito, Hiroyuki
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Kawaguchi, Toshiaki
    Habuchi, Tomonori
    Ohyama, Chikara
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 (12) : 1095 - 1100
  • [48] Impact of treatment line on outcomes with salvage ipilimumab plus nivolumab in metastatic renal cell carcinoma (mRCC).
    Kotecha, Ritesh
    Lee, Chung-Han
    Knezevic, Andrea
    Shah, Neil J.
    Carlo, Maria Isabel
    Feldman, Darren R.
    Patil, Sujata
    Motzer, Robert J.
    Voss, Martin H.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [49] Impact of cytoreductive nephrectomy prior to combination therapy of ipilimumab plus nivolumab in metastatic renal cell carcinoma
    Hara, Takuto
    Furukawa, Junya
    Shiraishi, Yusuke
    Okamura, Yasuyoshi
    Bando, Yukari
    Terakawa, Tomoaki
    Harada, Kenichi
    Nakano, Yuzo
    Fujisawa, Masato
    INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (09) : 746 - 752
  • [50] Clinical Activity of Ipilimumab Plus Nivolumab in Patients With Metastatic Non- Clear Cell Renal Cell Carcinoma
    Gupta, Ruby
    Ornstein, Moshe Chaim
    Li, Hong
    Allman, Kimberly D.
    Wood, Laura S.
    Gilligan, Timothy
    Garcia, Jorge A.
    Von Merveldt, Dendra
    Hammers, Hans J.
    Rini, Brian I.
    CLINICAL GENITOURINARY CANCER, 2020, 18 (06) : 429 - 435
12345